SEC
SlamSEC
SearchBrowseEarnings

PRECISION BIOSCIENCES INC

Nasdaq:DTIL
Biological Products, (No Diagnostic Substances)·DURHAM, NC
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

All Filings(553 total)

TypeDateAccessionPeriodSize
4
Feb 19, 2026
0001628280-26-009804FORM 4
Feb 17, 2026
8.8 KB
4
Feb 19, 2026
0001628280-26-009803FORM 4
Feb 17, 2026
8.8 KB
4
Feb 19, 2026
0001628280-26-009802FORM 4
Feb 17, 2026
8.8 KB
4
Feb 19, 2026
0001628280-26-009801FORM 4
Feb 17, 2026
9.5 KB
144
Feb 18, 2026
0001959173-26-001183
—
5.2 KB
144
Feb 18, 2026
0001959173-26-001166
—
5.0 KB
144
Feb 18, 2026
0001959173-26-001164
—
5.1 KB
144
Feb 18, 2026
0001959173-26-001157
—
5.0 KB
SCHEDULE 13G/A
Feb 17, 2026
0001214659-26-002023
—
13.1 KB
SCHEDULE 13G/A
Feb 17, 2026
0000902664-26-001048
—
10.5 KB
SCHEDULE 13G/A
Feb 13, 2026
0001420506-26-000426
—
10.6 KB
8-K
Feb 11, 2026
0001628280-26-0071148-K
Feb 11, 2026
173.5 KB
SCHEDULE 13G
Feb 10, 2026
0001214659-26-001399
—
11.9 KB
SCHEDULE 13G
Jan 27, 2026
0001716774-26-000005
—
8.6 KB
4
Jan 22, 2026
0001628280-26-003149FORM 4
Jan 20, 2026
16.5 KB
4
Jan 22, 2026
0001628280-26-003148FORM 4
Jan 20, 2026
16.1 KB
4
Jan 22, 2026
0001628280-26-003147FORM 4
Jan 20, 2026
16.0 KB
4
Jan 22, 2026
0001628280-26-003146FORM 4
Jan 20, 2026
17.0 KB
144
Jan 22, 2026
0001959173-26-000404
—
5.1 KB
SCHEDULE 13G
Jan 22, 2026
0000902664-26-000375
—
16.1 KB
144
Jan 21, 2026
0001959173-26-000389
—
5.0 KB
144
Jan 21, 2026
0001959173-26-000388
—
4.6 KB
144
Jan 21, 2026
0001959173-26-000387
—
5.0 KB
8-K
Jan 13, 2026
0001628280-26-0019558-K
Jan 12, 2026
182.0 KB
EFFECT
Jan 7, 2026
9999999995-26-000100
—
1.7 KB
25 filings shown

Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina.

CEO
Amoroso Michael
CFO
Kelly John Alexander